Human Polyclonal Daxx Ab
- Known as:
- Human Polyclonal Daxx Antibody
- Catalog number:
- a0186
- Product Quantity:
- USD
- Category:
- -
- Supplier:
- ABclonal
- Gene target:
- Human Polyclonal Daxx
Related genes to: Human Polyclonal Daxx Ab
- Gene:
- DAXX NIH gene
- Name:
- death domain associated protein
- Previous symbol:
- -
- Synonyms:
- DAP6
- Chromosome:
- 6p21.32
- Locus Type:
- gene with protein product
- Date approved:
- 1998-03-25
- Date modifiied:
- 2016-10-05
Related products to: Human Polyclonal Daxx Ab
Related articles to: Human Polyclonal Daxx Ab
- Valosin-containing protein (VCP), a conserved AAA ATPase hexamer, participates in multiple biological processes including ERAD, ubiquitin-dependent degradation by extracting misfolded proteins for proteasomal degradation. Although its interactions with cofactors are well-characterized, and its dysregulation is implicated in multisystem proteinopathy, amyotrophic lateral sclerosis, and cancer, the tissue-specific VCP interactomes underlying its functional versatility remain elusive. Here, we generated HA-N-tagged VCP knock-in mice via CRISPR/Cas9 strategy and performed affinity purification coupled with data-independent acquisition (DIA) mass spectrometry to systematically profile VCP interactors across eight mouse tissues, yielding a high-confidence dataset. We identified 923 robust VCP-binding partners, including established interactors (UBX2B, UFD1, proteasomal subunits) and novel candidates implicated in energy metabolism (TCA cycle, oxidative phosphorylation) and protein quality control (proteasome, ERAD). Notably, we validated the interaction of VCP to two hepatic candidate proteins, DAXX and PRKAG2 (AMPK γ2 regulatory subunit), using HepG2 cells. This study establishes the first in vivo atlas of the VCP interaction network, providing mechanistic insights into its tissue-specific roles and highlighting potential therapeutic avenues for VCP-related disorders. - Source: PubMed
Publication date: 2026/06/13
Wang NannanLi YiningLi NaShen LinruWang ChengzhiZhu HuimingZhou ZiyueDing YibingZhang JingziFang LeiBai Bing - Corticotroph adenomas include functioning tumors causing Cushing disease (CD) and silent corticotroph adenomas (SCA), which differ markedly in size, clinical presentation, and aggressiveness. The molecular basis for these differences remains incompletely understood. - Source: PubMed
Publication date: 2026/06/11
Paes TicianaZhang QilinBorges Clarice OrangeMohan Dipika RVaz VictorSoares Beatriz SantanaCarroll Rona SKaiser Ursula BSmith Timothy RBi Wenya LindaMeredith DavidLerario Antonio MAbreu Ana Paula - The antiviral protein MORC3 is frequently inhibited by viruses. To counteract viral antagonism, MORC3 represses a noncanonical pathway of type-I-interferon (IFN) such that viral inhibition of MORC3 triggers ( > 10,000-fold) IFN induction. How MORC3 represses this pathway, and why IFN induction upon MORC3 loss is so potent without canonical IRF3/7 transcription factors, is unknown. Here, we show that MORC3 restricts chromatin accessibility at tandem repeat elements harboring up to 61 homotypic transcription factor motifs. One such element becomes a potent enhancer of IFNB1 upon MORC3 loss. Its motif cluster contains 45 PU.1 binding sites and is necessary and sufficient for MORC3-mediated repression and enhancer activity upon MORC3 loss. PU.1 recruits MORC3 to repress this enhancer by recruiting DAXX and enabling H3.3 incorporation. Upon MORC3 loss, PU.1 drives IRF3/7-independent IFN induction. Other restricted tandem repeats contain homotypic motif clusters of SPI, AP-1, and SP/KLF transcription factors. Our findings uncover a TF motif cluster-driven repression mechanism by MORC3 at tandem repeats, enabling specific repression of an IFNB1 enhancer such that viral antagonism of MORC3 induces interferon. - Source: PubMed
Publication date: 2026/06/05
Krumwiede LuisaHollaus DavidValeri ErikaSchindler-Schumitsch KarinaBazyl Monika ASchiedlbauer JohannaBecht Nanette NJaritz Markusde Almeida Bernardo PSchloissnig SiegfriedBurdette Dara LSchreiber JacobStark AlexanderGaidt Moritz M - The goal of this study was to explore the biological mechanisms that may influence the development of myofibromas, noninvasive soft tissue tumors with a variable clinical course. Although solitary lesions are usually benign, multicentric infantile myofibromatosis can range from indolent disease with spontaneous regression to severe forms with visceral involvement and life-threatening complications. - Source: PubMed
Publication date: 2026/05/29
Boulouadnine BoutainaRovira Zurriaga CarlotaGofflot StéphanieBrichard BénédicteDecottignies AnabelleDemoulin Jean-Baptiste - Pancreatic neuroendocrine tumors (PanNETs) are clinically heterogeneous, and conventional risk stratification based on tumor size, grade, and stage often fails to capture the full spectrum of biological behavior, especially among small (≤ 2 cm), non-functioning tumors where management remains controversial. - Source: PubMed
Publication date: 2026/05/29
Cheong Kai XuanZhang Lu-TingWang Ya-ZhouGan WeiLiu Chen-ChenYing YingPeng Mao-ZhenTang Lin-HuiLiu LiangWang Wen-Quan